The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Privia Health Group Inc shares valued at $2,810,612 were purchased by Boehler Adam on May 23 ’24. At $16.28 per share, Boehler Adam acquired 172,642 shares. The insider’s holdings grew to 5,763,572 shares worth approximately $92.85 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, McCarthy Thomas A purchased 10,000 shares, netting a total of over 163,700 in proceeds. Following the buying of shares at $16.37 each, the insider now holds 52,611 shares.
Before that, Boehler Adam had added 102,229 shares to its account. In a trade valued at $1,679,622, the Director bought Privia Health Group Inc shares for $16.43 each. Upon closing the transaction, the insider’s holdings increased to 102,229 shares, worth approximately $90.07 million.
As published in their initiating research note from Citigroup on April 22, 2024, Privia Health Group Inc [PRVA] has been a Buy and the price target has been revised to $25. Analysts at Barclays started covering the stock with ‘”an Equal weight”‘ outlook in a report released in early March. Earlier on February 22, 2024, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for PRVA stock which previously was a “a Buy”.
Analyzing PRVA Stock Performance
During the last five days, there has been a drop of approximately -5.24%. Over the course of the year, Privia Health Group Inc shares have dropped approximately -30.05%. Shares of the company reached a 52-week high of $24.05 on 01/02/24 and a 52-week low of $15.92 on 05/21/24. A 50-day SMA is recorded $18.48, while a 200-day SMA reached $21.59. Nevertheless, trading volume fell to 1.21 million shares from 1.17 million shares the previous day.
Support And Resistance Levels for Privia Health Group Inc (PRVA)
According to the 24-hour chart, there is a support level at 15.90, which, if violated, would cause prices to drop to 15.68. In the upper region, resistance lies at 16.44. The next price resistance is at 16.76. RSI (Relative Strength Index) is 31.37 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.29, which suggests the price will decrease in the coming days. Percent R is at 94.59%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
